Lexicon Pharmaceuticals, Inc. (LXRX) Stock buybacks 2015–2024
Lexicon Pharmaceuticals, Inc. (LXRX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$1.7MFY2024 · since FY2015: $357,000 → $1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $1.7M | +110.0% |
| FY2023 | $824,000 | -4.6% |
| FY2022 | $864,000 | -67.7% |
| FY2021 | $2.7M | +160.7% |
| FY2020 | $1.0M | +9.0% |
| FY2019 | $941,000 | -3.2% |
| FY2018 | $972,000 | -42.1% |
| FY2017 | $1.7M | +170.4% |
| FY2016 | $621,000 | +73.9% |
| FY2015 | $357,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice